This study is in progress, not accepting new patients
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Summary
- Eligibility
- for people ages 20-80 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Nadine Abi-Jaoudeh, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Nadine Abi-Jaoudeh, MD
Clinical Professor, Radiological Sciences. Authored (or co-authored) 40 research publications.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Teclison Ltd.
- ID
- NCT02174549
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated